Andere Sprachen CEL-SCI Corporation

Aktien

A2DY0D

US1508376076

CVM

Realtime-Estimate Cboe BZX Andere Börsenplätze 15:56:56 07.05.2024			% 5 Tage	% 1. Jan.
1.65 ^USD	-4.07%		+16.44%	-37.50%

23.04.	CEL-SCI Corporation ernennt Mario Gobbo zum Vorstandsmitglied	CI
14.02.	CEL-SCI Corporation meldet Ergebnis für das erste Quartal bis zum 31. Dezember 2023	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

CEL-SCI Appoints Mario Gobbo to Its Board of Directors	23.04.
CEL-SCI Corporation Appoints Mario Gobbo as Board of Directors	23.04.
CEL-SCI’s LEAPS Vaccine Offers Promising New Paradigm to Treat Rheumatoid Arthritis: Published in Frontiers in Immunology	19.03.
CEL-SCI Corporation Issues Letter to Shareholders	06.03.
CEL-SCI Corporation Reports First Quarter Fiscal 2024 Financial Results	15.02.
Cel-Sci: Fiscal Q1 Earnings Snapshot	14.02.
CEL-SCI Corporation Reports Earnings Results for the First Quarter Ended December 31, 2023	14.02.
Cel-Sci Closes $7.8 Million Share Offering	13.02.
CEL-SCI Announces Closing of $7.75 Million Public Offering of Common Stock	13.02.
CEL-SCI Announces Pricing of $7.75 Million Public Offering of Common Stock	12.02.
Health Care Slips on Rotation to High-Risk Sectors -- Health Care Roundup	10.02.
Cel-Sci Prices $7.8 Million Public Offering of Common Shares	09.02.
CEL-SCI Announces Pricing of $7.75 Million Public Offering of Common Stock	09.02.
CEL-SCI Completes Commissioning of Its Multikine Manufacturing Facility for Commercial Scale Production of Head and Neck Cancer Drug	07.02.
CEL-SCI Completes Commissioning of Its Multikine Manufacturing Facility for Commercial Scale Production of Head & Neck Cancer Drug	06.02.
CEL-SCI Corporation Completes Commissioning of Its Multikine Manufacturing Facility for Commercial Scale Production of Head & Neck Cancer Drug	06.02.
European Medicines Agency Grants CEL-SCI a Waiver of Strict Pediatric Requirements, Clearing the Path towards Marketing Authorization for Multikine	01.02.
Sector Update: Health Care Stocks Mixed Late Wednesday Afternoon	31.01.
Sector Update: Health Care Stocks Gain in Afternoon Trading	31.01.
Cel-Sci Receives Pediatric Requirements Waiver for Multikine From European Medicines Agency	31.01.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen CEL-SCI Corporation

Aktien

A2DY0D

US1508376076

CVM

Andere Sprachen

Filter